Trends of Cancer Incidence and Mortality in Russia

Sponsor
ITMO University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06122857
Collaborator
(none)
100,000
1
38.8
2579.4

Study Details

Study Description

Brief Summary

The study aims to assess the dynamics of incidence and mortality for all major groups of cancers for which the national data is available for the longest possible time series. The data obtained from publicly available sources are used.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100000 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Trends of Cancer Incidence and Mortality in Russia: the Breakpoint and Age-period-cohort Analyses of Cancer Incidence and Mortality
    Actual Study Start Date :
    Oct 2, 2023
    Anticipated Primary Completion Date :
    Dec 25, 2026
    Anticipated Study Completion Date :
    Dec 25, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Cancer incidence [30 years]

    2. Cancer mortality [30 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    0 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Non applicable

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ITMO University Saint Petersburg Russian Federation 197198

    Sponsors and Collaborators

    • ITMO University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    ITMO University
    ClinicalTrials.gov Identifier:
    NCT06122857
    Other Study ID Numbers:
    • FSER-2022-0013
    First Posted:
    Nov 8, 2023
    Last Update Posted:
    Nov 8, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 8, 2023